Next Article in Journal
From Food to Hospital: We Need to Talk About Acinetobacter spp.
Previous Article in Journal
Occurrence of Cryptococcus neoformans and Other Yeast-like Fungi in Environmental Sources in Bonaire (Dutch Caribbean)
 
 
GERMS is published by MDPI from Volume 15 Issue 4 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with the former publisher Infection Science Forum.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Burden of Influenza in Romania. A Retrospective Analysis of 2014/15–2018/19 Seasons in Romania

by
Adrian Pană
1,*,
Adriana Pistol
2,
Adrian Streinu-Cercel
3 and
Bogdan-Vasile Ileanu
4
1
Center for Health Outcomes & Evaluation, Splaiul Unirii 45, Bloc M15, Ap. 55, District No. 3, Bucharest, Romania
2
National Institute of Public Health, Doctor Leonte Anastasievici No. 1-3, Bucharest, Romania
3
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Carol Davila University of Medicine and Pharmacy Bucharest, No. 1 Dr. Calistrat Grozovici Street, Bucharest, Romania
4
Center for Health Outcomes & Evaluation, Bucharest University of Economic Studies, Piața Romană 6, 010374 Bucharest, Romania
*
Author to whom correspondence should be addressed.
GERMS 2020, 10(3), 201-209; https://doi.org/10.18683/germs.2020.1206
Submission received: 2 June 2020 / Revised: 4 August 2020 / Accepted: 20 July 2020 / Published: 1 September 2020

Abstract

Introduction: Influenza is a seasonal epidemic with a heavy negative impact both on population health, and healthcare system utilization; until now, there are only two burden of disease studies in the Romanian context. This study aims to quantify the burden of influenza for the Romanian population for the seasons 2014/15 to 2018/19, using health administrative databases. Methods: Incidence, hospitalization and mortality rates attributable to influenza as well as total number of influenza cases and deaths were estimated, for each season in the analyzed period, by combining the new cases reported by General Practitioners, Emergency Department presentations, hospitalizations, number of deaths, positivity rate of influenza, and probability to be consulted by a physician. Years of life lost due to premature death attributable to influenza complications were also computed. Results: On average, 591,151 cases/season attributable to influenza were estimated during the period 2014/15 -2018/19. The highest rates for incidence, hospitalization and presentation to emergency department were found in the age groups 0-4 years and 65 years and above. Influenza mortality rate was estimated at 3 per 100,000 persons and the 65 and above age group had the highest rate. Conclusions: About 3% of the total Romanian population is estimated to develop an influenza attributable disease in a non-pandemic season. An overall increasing trend of the mortality rate attributable to influenza may be also underlined. On average, a person loses 12 years due to premature death caused by complications of influenza.

Introduction

Influenza is a preventable seasonal disease with an epidemic character that has a significant negative impact on a yearly basis, on large population groups, healthcare systems, and countries’ economic performance, and reliable information regarding its burden throughout the world is still posing a major problem [1]. According to the World Health Organization (WHO), the global influenza epidemic affects between 5-10% of the adult population annually, and around 20-30% of children [2]. Even though starting with 2011 the case definition for influenza was updated [3], and in 2015 the WHO issued a methodology for the estimation of disease burden associated with seasonal influenza [4], there is still a high heterogeneity in reporting the results [1,5,6]. The majority of influenza burden studies performed in the European setting have so far been concentrated on Western European countries rather than Central and Eastern European countries. Currently, for Romania, there are only two published studies regarding the burden of influenza, one taking into account the population 65 years and above [7], and the other one, the entire population at risk of developing influenza-like illness and severe acute respiratory infections, based on national surveillance data [8]. The current study attempts to measure the burden of influenza on five influenza seasons (2014/2015 -2018/2019), by employing a different methodology compared to the previous studies, and using the morbidity data reported at the national level in the health administrative databases for three levels of care: general practitioner (GP) offices, emergency departments and hospitals, as opposed to the existing studies that used surveillance network data only.
According to Preaud and colleagues [9], improving the vaccination rate in the European Union (EU) population from about 45% to 75%, for at-risk groups, would have a significant annual impact in diminishing the negative outcomes of this disease, from both a public health and economic perspective.
In Romania, the influenza vaccination rate has steadily decreased from 49.4% during the 2008/2009 season to 7.4% during the 2014/2015 season in the age group of 65 years and above [10]. During the last influenza seasons, the evolution of the vaccination rate for this age group has been variable and for the 2018/2019 season it reached 20.9%.[11,12] Also, regarding the influenza vaccination rate in the general population, although it has increased considerably for the past influenza seasons, it still did not exceed 7%[11,12] in the analyzed period and this trend impacts directly the burden of influenza in Romania.

Study Objective

The study aims to evaluate the burden of influenza associated illness in Romania by using information extracted from the morbidity and mortality healthcare administrative databases at national level in contrast with previous studies that were using information and estimation from the surveillance data network. The study also aims to cover the entire spectrum of burden of influenza associated illness by estimating data about morbidity, mortality and premature death.

Methods

The raw aggregated data regarding the number of new cases, hospitalization episodes and number of deaths were provided by the Statistical Center of the National Institute of Public Health (NIPH)[12] from national medical administrative databases for morbidity and mortality, covering all medical providers in Romania. Datasets were received in aggregated format for different providers and periods as follows: new cases at GP level, for entire seasons 2014/15 to 2018/19, new cases at hospital level and deaths for the entire seasons 2014/15 to 2017/18, and for the first part of the season 2018/2019 (until the end of December 2018). For the rest of the season 2018/19, (January-May 2019), values were estimated accordingly. The approach used in the current paper to estimate the number of cases attributable to influenza is described below.
For the total number of reported GP cases/season and the corresponding incidence, first, we counted all cases reported by general practitioners with the following diagnoses: Influenza with identified virus (J10.x), and Influenza with unidentified influenza virus (J11.x). Since a number of initial influenza cases advance to more severe respiratory disease (infections) such as pneumonia, using only the influenza reported cases by specific diagnosis codes would determine an underestimation of the burden of influenza associated illness. Thus, using the influenza positivity rate (IPR), computed from WHO-FluNet[13] data, we extracted all cases reported by GPs with the diagnosis Unspecified viral pneumonia (J12.x), and Other pneumonias with unspecified organisms (J18.x), as a share equal to IPR.
The GP incidence attributable to influenza (InI) in a season s for an age group a was computed using the relation:
Germs 10 00201 i001
Where season s starts from 2014/2015 to 2018/19 and age group a represents the 0-4, 5-19, 20-49, 50-64 and 65 and above age groups.
The Pas represents the resident population for age group a and season s. The values for the population were available at the National Institute of Statistics, TEMPO Database [14].
For the period analyzed, the IPR for Romania varied by season, starting with 0.540 for 2014/15 season, followed by 0.487 in 2015/16, 0.432 in 2016/17, 0.563 in 2017/18 and 0.478 in 2018/19.
The data for the number of presentations to Emergency Departments (EDs) attributable to influenza was requested from the Romanian Department for Emergency Situations for the all seasons analyzed. However, raw data was provided only for seasons 2017/18 to 2018/19. The dataset comprised cases at national level by season regarding the attendance to emergency units by persons with influenza-like illness symptomatology according to ECDC criteria[15] (E-ILIs). Data for unavailable seasons were estimated due to absence of raw dataset.
The number of Emergency Department presentations attributable to influenza (EAI) were calculated as IPR * E-ILIs for each season s. Using this assumption, the emergency rates attributable to influenza (ERI) by season s, becomes:
Germs 10 00201 i002(2)
The decomposition of ERIs by age group was made, using as proxy such as the structure of cases by age group from the hospital morbidity database.
A certain number of influenza cases do not seek care at healthcare providers. Therefore, these are considered non-consulting cases. The non-consulting cases are estimated using the probability p to consult a GP. Because no data are available for Romania, we used the value proposed by Carrat and colleagues [16], p=0.49. Then, the non-consulting cases were computed as p/(1-p)*GP cases.
Using all these categories of patients with influenza attributable disease we computed the total number of attributable influenza cases (TCI) per season, for each age group using the relation:
TCI = non-consulting cases + GPs reported cases + presentation to EDs. Therefore, by reporting to the resident population Pas, the total influenza attributable disease rate was obtained. In order to avoid duplication of cases, hospitalizations were accounted for separately, due to the fact that persons admitted in the hospital are counted already either at EDs before admission or at GPs, before admission (referral to hospital) or after discharge (medical leave or/and reimbursed prescription at GPs).
For the inpatient and day-hospital care, we counted all the episodes discharged with the primary diagnosis according to ICD-10 any of the following: J10.0 Influenza due to other identified influenza virus with pneumonia; J10.1 Influenza due to other identified influenza virus with other respiratory manifestations; J10.2 Influenza due to other identified influenza virus with gastrointestinal manifestations; J10.8 Influenza due to other identified influenza virus with other manifestations; J11.0 Influenza due to unidentified influenza virus with pneumonia; J11.1 Influenza due to unidentified influenza virus with other respiratory manifestations; J11.2 Influenza due to unidentified influenza virus with gastrointestinal manifestations; J11.8 Influenza due to unidentified influenza virus with other manifestations.
Then using the IPRs, defined in the previous paragraph, we extracted from all pneumonia discharged cases (J12.x and J18.x), for each season, a share equal to IPR. Based on previous seasons data, 30% of inpatient hospitalization episodes, as well as 25% of day-hospitalizations episodes attributable to influenza, occurred during the first part of the seasons (October-December). In order to compute the total number of episodes for the entire season 2018-2019, the available number of episodes were divided by 0.3, respectively by 0.25, and summed accordingly.
The attributable influenza hospitalization rate (IHR) for an age group a, type of hospitalization, h and season s becomes:
Germs 10 00201 i003
For the mortality rate, we counted all deaths reported in a season with the main cause being any of J10.0 to J11.8 (influenza). According to other studies,[17,18] 10% of deaths with the main cause pneumonia (any of the ICD-10 codes {J12.0; J12.9} ꓴ {J18.0; J18.9}) could be attributable to influenza. The estimation for the number of deaths for the missing season 2018/19 was done as follows:
For age groups [0-4 years old] and [65+] the number of deaths has a trend in the last seasons. For both age groups the models are:
Germs 10 00201 i004
where (Mt) = number of deaths in the season t, t=1..10 seasons, ut = error term.
Then, using data from the last 10 seasons, the parameters for each model were estimated. For the other age groups, [5-19], [20-49] and [50-64], the number of deaths were computed taking the mean for the last seasons, since no trend was identified.
Then the mortality rates are
Germs 10 00201 i005
In both (3) and (4) relations, a represents the age group and s the seasons, the same as described for the relation (1).
The non-discounted value of the years of life lost (YLL) due to premature death attributable to influenza complications was calculated using the relation:
Germs 10 00201 i006
Where a = the age group, Agea = mean of the age group a, Da = number of deaths in the interval and LE=74 years, the life expectancy at birth in Romania [19]. Then, the average YLL per death was also derived [20].

Results

Most cases of influenza infections reported by GPs for the analyzed period were found in children, followed by cases in the age group 65 years and above that had a number of cases very close to that occurring in the age groups 20-49 and 50-64 years. In the age group 0-4 years, the incidence of influenza was 4 times higher than in the age group over 65 years. The lowest influenza incidence reported by GPs was found in the adults 20-49 years, with a value five times smaller than that for the 0-4 years age group. According to current estimation, the total number of new cases reported by GPs, per season, varied in the analyzed period from a minimum of 108,412 cases in season 2016/17 to a maximum of 181,541 cases, in 2018/19. During the entire period the average number of cases per season was 146,178 (Table 1).
Except for the 0-4 year age group, which had an increasing trend of presentations at EDs for the analyzed period, with the highest values recorded (2,500-4,000 cases/100,000 persons), the other age groups had relatively constant presentation rates during the analyzed period, and at values up to 5-10 times lower than the values recorded for the age group 0-4 years (Table 2).
The total number of cases of influenza attributable disease reached, on average, 591,151 cases/season, with a maximum of 671,479 cases estimated for the season 2018/19 (Figure 1). This implies that in average around 3% of the Romanian population is estimated to develop an influenza attributable disease in a season.
Hospital admission rates fluctuated from one season to another. For inpatient care, in the last five seasons the range was 153 to 220 influenza attributable disease episodes per 100,000 persons/season. The hospitalization rates in day-hospital care were significantly lower, values did not reach more than 91 influenza attributable disease episodes per 100,000 persons/season in the studied period. Infections attributable to influenza virus were responsible for 33,000 to 45,000 inpatient hospitalizations in Romania every season.
Children aged 0-4 years represented the most frequent age group hospitalized in inpatient care for influenza infections, with an average number of 1000 episodes of hospitalization per 100,000 persons/season. The second age group most frequently hospitalized was represented by 65 years and older, with an average number of 250 episodes of continuous hospitalization per 100,000 persons/season.
The most frequent, day-hospitalizations occurred in the 0-4 years age group, with a rate of ~150-214 episodes/100,000 persons. Persons from the age groups 5-19 years and 50-64 years had similar rates during the seasons 2014/15-2016/17, with values ranging from 75 to 115 episodes/100,000 persons. In the last two influenza season evaluated, the persons in the age group 65 and above had an important increase in the day-hospitalization episodes, the correspondent day-hospitalization rate for this age group doubled its value, compared with the beginning of the period. The lowest number of cases during the entire period of analysis were those from the 20-49 years age group. The day-hospitalization rate of this age group was ~3 times lower than the maximum rate observed.
In terms of hospitalization, there were 33,000 to 45,000 cases per season, representing ~7% from the total estimated number of influenza cases/season (Table 3).
The estimations showed a negative trend for the 0-4 age group, log(Mt) = 1.779 - 0.040 * t and for the 65+ age group, log(Mt) = 2.250 + 0.034 * t, respectively. Then, a number of 22 deaths were estimated for the first group and 428 for the last one. Summing the estimated deaths from all age groups, a total number of 625 deaths were counted for the entire 2018/19 season.
An average of 577 deaths per season was estimated for the period 2014/15-2018/19 with a maximum of 664 deaths in season 2017/18.
The crude mortality rate for influenza infections, although low, increased steadily for the analyzed period and had values between two and three deaths per 100,000 persons.
The highest mortality rate due to infections attributable to influenza was found in the elderly group (65+). Here the values were 4 to 5 times higher than the values attributable to the 50-64 age group, and about 50 times higher than those of the 5-49 age group. Also, the mortality rate for the elderly group had an increasing trend, while for the other groups the rates were stable, in the analyzed period. A slightly decreasing trend of the mortality rate could be observed for the 0-4 years age group: in the 2014/15 season the rate was 3.1 deaths at 100,000 persons and in the last analyzed season it reached 2.2 deaths per 100,000 persons (Figure 2).
Based on the National Institute of Statistics mortality data[14] and the current computations, it was estimated that the number of deaths attributable to influenza represents in a season almost 0.25% of all causes of deaths, registered in a year in Romania.
During the analyzed seasons, an average of 6,882 potential years of life lost (PYLL)/season were estimated due to premature death attributable to influenza. This value represents an average of 35.2 years lost/100,000 persons.

Discussion

In the analyzed period a sinuous tendency may be seen for most of the indicators. This tendency suggests the alternance of high-low intensity of influenza seasons, and this pattern might be influenced by the inconstant vaccination rate especially for risk groups, and the predominant strains circulating in a season.
According to the methodology used in this study, the incidence of influenza attributable disease varied between 250-350 cases per 100,000 persons for the analyzed period. As a comparison, the incidence of influenza-like illness reported from the sentinel network throughout the country for the same period was much lower and highly variable, with values between 16 and 120 cases reported per 100,000 persons [19].
The burden of influenza attributable illness in Romania appears to be ten times higher than the one reported by Gefenaite in 2017 [8]. One of the main differences in the estimation of this final value is linked with the methodology used in this study, as compared with the one used in the study by Gefenaite, which was based on sentinel network reported events only.
Further qualitative studies should be employed in order to have a better understanding of the response behavior of persons working in the sentinel network. Also, another suggestion might be to include some EDs in the sentinel network for influenza.
A high variation between the analyzed age groups was observed. In particular, the age groups 0-4 and 65 and above were the highest at-risk groups for influenza attributable disease.
The most affected age group in terms of influenza attributable morbidity was 0-4 years old, both in this research as well as in the studies by Gefenaite et al [8]. and Meerhoff et al [21]. In line with the results achieved by Cromer al. (2014) for England [22], in terms of hospital admission, the 0-4 age group had the leading rate, while the 65 and above group followed it. The highest hospitalization rates for the age groups 0-4 and 65 were described also by Mattias et al. (2016)[23] for UK, but here, the leading group found was the elderly.
One possible hypothesis for the high number of cases from the age group 0-4 is the fact that this group had the lowest vaccination rate for influenza (CNSCBT) [11]. Also, it is customary for hospitals to admit even mild cases particularly for the age group 0-4 years old, either for better monitoring or for parents’ comfort.
The most affected group in terms of influenza attributable mortality was the age group 65 years and above, the same leading age group being reported in the studies by Kovacs et al. from 2014 [7], and by Mattias et al. (2016) [23].
A potential hypothesis is that mortality attributable to influenza is underreported, mostly by the lack of evidence of the causal etiologic agent, also by mentioning the most frequent acute complication (e.g., acute respiratory failure, bronchopneumonia, sepsis, cardiac arrest) as the primary cause of death.
Moreover, beside the different methodological approach, the sentinel network might not be able to capture statistically representative data in order to provide a more accurate estimation of incidence of influenza attributable illnesses.
While studies from other countries[24] show benefits in terms of morbidity and mortality reduction in case of higher vaccination coverage, the increase of low vaccination rates registered in Romania may be a challenge. According to the Organization for Economic Co-operation and Development (OECD) [25], influenza mortality may be avoided by preventative measures, one of them being vaccination.

Conclusions

About 3% of the total Romanian population is affected by influenza in a non-pandemic season and the most affected age group is 0-4 years old with the second most affected group being the elderly. There is an overall tendency of increased mortality rate attributable to influenza for the analyzed period especially for the age group 65 years old and above.
Further studies regarding the cost-effectiveness of influenza vaccination in Romania, especially for the age group 0-4 years old, should be performed.

Author Contributions

A Pană designed the paper. BI analyzed the available data. A. Pană, A. Pistol, ASC and BI wrote or revised the manuscript. All authors read and approved the final version of the manuscript.

Funding

The paper represents a partial finding of a research study that was financed by Sanofi Romania. The funder had no role in study design, data collection and analysis, and contributed to the decision to publish and provided feedback on the first draft of the manuscript.

Acknowledgments

The authors thank all their collaborators who helped them during the current study. The authors also thank the reviewers for the insightful comments.

Conflicts of Interest

ASC was principal investigator in influenza clinical trials by Roche, and speaker for Sanofi. All other authors—none to declare.

References

  1. Lee, V.J.; Ho, Z.J.M.; Goh, E.H. , et al. Advances in measuring influenza burden of disease. Influenza Other Respir Viruses. 2018, 12, 3–9. [Google Scholar] [CrossRef] [PubMed]
  2. Vaccines against influenza WHO position paper -November 2012. Wkly Epidemiol Rec. 2012, 87, 461–476.
  3. Fitzner J, Qasmieh S, Mounts AW, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018, 96, 122–128. [Google Scholar] [CrossRef] [PubMed]
  4. WHO Global Influenza Programme. A manual for estimating disease burden associated with seasonal influenza. Geneva, Switzerland: WHO; 2015.
  5. An der Heiden, M.; Buchholz, U. Estimation of influenza-attributable medically attended acute respiratory illness by influenza type/subtype and age, Germany, 2001/02-2014/15. Influenza Other Respir Viruses. 2017, 11, 110–121. [Google Scholar] [CrossRef] [PubMed]
  6. Fleming, D.M.; Taylor, R.J.; Haguinet, F. , et al. Influenza-attributable burden in United Kingdom primary care. Epidemiol Infect. 2016, 144, 537–547. [Google Scholar] [CrossRef] [PubMed]
  7. Kovács, G.; Kaló, Z.; Jahnz-Rozyk, K. , et al. Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother. 2014, 10, 428–440. [Google Scholar] [CrossRef] [PubMed]
  8. Gefenaite, G.; Pistol, A.; Popescu, R. , et al. Estimating burden of influenza-associated influenza-like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12-2015/16 influenza seasons. Influenza Other Respir Viruses. 2018, 12, 183–192. [Google Scholar] [CrossRef] [PubMed]
  9. Preaud, E.; Durand, L.; Macabeo, B. , et al. Annual public health and economic benefits of seasonal influenza vaccination: a European estimate. BMC Public Health. 2014, 14, 813. [Google Scholar] [CrossRef] [PubMed]
  10. Jorgensen, P.; Mereckiene, J.; Cotter, S.; Johansen, K.; Tsolova, S.; Brown, C. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine 2018, 36, 442–452. [Google Scholar] [CrossRef] [PubMed]
  11. National Center for Surveillance and Control of Communicable Diseases (CNSCBT) within the National Institute of Public Health (NIPH). Available online: https://www.cnscbt.ro/ (accessed on day month year).
  12. National Institute of Public Health (NIPH), National Centre for Surveillance and Control of Communicable Diseases. Available online: https://cnsisp.insp.gov.ro/ (accessed on 28 July 2020).
  13. World Health Organization (WHO). FluNet. Available online: https://apps.who.int/flumart/Default? (accessed on day month year).
  14. National Institute of Statistics (NIS), Tempo Database, 2020. Accessed on: . Available at: , code POP105A. Available online: http://statistici.insse.ro:8077/tempo-online/ (accessed on 28 July 2020).
  15. Commission implementing decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. (OJ L 170, 6.7. Commission implementing decision (EU) 2018/945 of on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. (OJ L 170, 6.7.2018, p. 24). Available online: https://eur-lex.europa.eu/legal- content/EN/TXT/PDF/?uri=CELEX:32018D0945&fro m=EN#page=24 (accessed on day month year).
  16. Carrat, F.; Vergu, E.; Ferguson, N.M.; et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008, 167, 775–785. [Google Scholar] [CrossRef] [PubMed]
  17. Davis, K.; Staes, C.; Duncan, J.; Igo, S.; Facelli, J.C. Identification of pneumonia and influenza deaths using the Death Certificate Pipeline. BMC Med Inform Decis Mak. 2012, 12, 37. [Google Scholar] [CrossRef] [PubMed]
  18. Noymer, A.; Nguyen, A.M. Influenza as a proportion of pneumonia mortality: United States, 1959-2009. Biodemography Soc Biol. 2013, 59, 178–190. [Google Scholar] [CrossRef] [PubMed]
  19. National Institute of Statistics (NIS), Tempo Database, 2020. Available online: https://eur-lex.europa.eu/legal- content/EN/TXT/PDF/?uri=CELEX:32018D0945&fro m=EN#page=24 (accessed on day month year).
  20. Aragón, T.J.; Lichtensztajn, D.Y.; Katcher, B.S.; Reiter, R.; Katz, M.H. Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health. 2008, 8, 116. [Google Scholar] [CrossRef] [PubMed]
  21. Meerhoff, T.J.; Simaku, A.; Ulqinaku, D. , et al. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region—an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases. BMC Infect Dis. 2015, 15, 1. [Google Scholar] [CrossRef] [PubMed]
  22. Cromer, D.; van Hoek, A.J.; Jit, M.; Edmunds, W.J.; Fleming, D.; Miller, D. The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy. J Infect. 2014, 68, 363–371. [Google Scholar] [CrossRef] [PubMed]
  23. Matias, G.; Taylor, R.J.; Haguinet, F.; Schuck-Paim, C.; Lustig, R.L.; et al. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom. BMC Public Health. 2016, 16, 481. [Google Scholar] [CrossRef] [PubMed]
  24. Ray, R.; Dos Santos, G.; Buck, P.O. , et al. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Hum Vaccin Immunother. 2017, 13, 1640–1652. [Google Scholar] [CrossRef] [PubMed]
  25. Organisation for Economic Co-operation and Development (OECD). Avoidable mortality: OECD/Eurostat lists of preventable and treatable causes of death (November 2019 version). 2019. Available online: https://www.oecd.org/health/health-systems/Avoidable- mortality-2019-Joint-OECD-Eurostat-List-preventable- treatable-causes-of-death.pdf (accessed on day month year).
Figure 1. The number and corresponding rates for total influenza attributable cases per season.
Figure 1. The number and corresponding rates for total influenza attributable cases per season.
Germs 10 00201 g001
Figure 2. The dynamics of mortality rate attributable to influenza by season and age group.
Figure 2. The dynamics of mortality rate attributable to influenza by season and age group.
Germs 10 00201 g002
Table 1. The incidence, total number of new cases at GP level and the non-consulting cases attributable to influenza.
Table 1. The incidence, total number of new cases at GP level and the non-consulting cases attributable to influenza.
TypeAge groupCases per 100,000 persons
Season
2014/15
Season
2015/16
Season
2016/17
Season
2017/18
Season
2018/19
New cases at GP0-4 years2,737.42,038.71,763.02,265.53,028.7
5-19 years1,492.81,098.4905.51,080.81,438.4
20-49 years588.9446.4371.4480.7652.3
50-64 years666.7501.0431.4568.9734.1
65 years and above731.7524.1453.4592.6772.3
Total877.8652.5551.9704.2935.7
Total number of new cases at GP174,465128,941108,412137,531181,541
Non-consulting Cases0-4 years2,630.11,958.81,693.92,176.72,909.9
5-19 years1,434.31,055.3870.01,038.41,382.0
20-49 years565.8428.9356.8461.8626.7
50-64 years640.6481.4414.5546.6705.3
65 years and above703.0503.5435.6569.4742.0
Total843.4626.9530.3676.6899.0
Total non-consulting cases167,623123,884104,160132,137174,421
Table 2. The presentation to EDs rates and total number attributable to influenza.
Table 2. The presentation to EDs rates and total number attributable to influenza.
Age groupPresentation at EDs per 100,000 persons
Season
2014/15
Season
2015/16
Season
2016/17
Season
2017/18
Season
2018/19
0-4 years2588.72939.02832.23616.43905.5
5-19 years920.61032.8913.11224.61050.3
20-49 years385.9452.9438.3592.5465.6
50-64 years461.2509.9511.5767.3537.8
65 years and above588.7637.4622.8876.3596.0
Total630.0712.9680.4932.1776.1
Total number of EDs presentations attributable to influenza125,218140,87733,666182,040150,568
EDS—emergency departments.
Table 3. The inpatient and day-hospitalization rates and number of episodes attributable to influenza.
Table 3. The inpatient and day-hospitalization rates and number of episodes attributable to influenza.
Hospitalization typeAge groupEpisodes per 100,000 persons
Season
2014/15
Season
2015/16
Season
2016/17
Season
2017/18
Season
2018/19
Inpatient care (continuous)0-4 years1,253.8982.8898.61,121.31,253.6
5-19 years214.3163.1143.5165.7210.5
20-49 years77.962.352.377.456.1
50-64 years185.0150.4141.6170.7169.4
65 years and above263.9195.0209.4366.3362.8
Total208.9162.7153.4214.8220.2
Total number of episodes in inpatient care41,51932,15430,12941,95142,729
Day-hospitalization0-4 years213.6158.3147.2184.3174.2
5-19 years115.878.475.2137.790.1
20-49 years68.844.043.949.263.7
50-64 years116.275.177.981.396.8
65 years and above62.141.844.2102.5108.3
Total91.460.660.486.088.2
Total number of episodes in day-hospitalization18,162 11,974 11,862.95 16,793 17,121

Share and Cite

MDPI and ACS Style

Pană, A.; Pistol, A.; Streinu-Cercel, A.; Ileanu, B.-V. Burden of Influenza in Romania. A Retrospective Analysis of 2014/15–2018/19 Seasons in Romania. GERMS 2020, 10, 201-209. https://doi.org/10.18683/germs.2020.1206

AMA Style

Pană A, Pistol A, Streinu-Cercel A, Ileanu B-V. Burden of Influenza in Romania. A Retrospective Analysis of 2014/15–2018/19 Seasons in Romania. GERMS. 2020; 10(3):201-209. https://doi.org/10.18683/germs.2020.1206

Chicago/Turabian Style

Pană, Adrian, Adriana Pistol, Adrian Streinu-Cercel, and Bogdan-Vasile Ileanu. 2020. "Burden of Influenza in Romania. A Retrospective Analysis of 2014/15–2018/19 Seasons in Romania" GERMS 10, no. 3: 201-209. https://doi.org/10.18683/germs.2020.1206

APA Style

Pană, A., Pistol, A., Streinu-Cercel, A., & Ileanu, B.-V. (2020). Burden of Influenza in Romania. A Retrospective Analysis of 2014/15–2018/19 Seasons in Romania. GERMS, 10(3), 201-209. https://doi.org/10.18683/germs.2020.1206

Article Metrics

Back to TopTop